WhiteOak Capital Pharma and Heathcare Fund
- Sectoral
- Wild
- WhiteOak Capital Mutual Fund
- Direct · Growth
NAV ₹18.45 · 20 Nov
| Date | NAV |
|---|---|
| 19 Nov 2025 | ₹14.54 |
| 4 Dec 2025 | ₹14.51 |
| 18 Dec 2025 | ₹14.12 |
| 5 Jan 2026 | ₹14.34 |
| 21 Jan 2026 | ₹13.52 |
| 6 Feb 2026 | ₹13.74 |
| 20 Feb 2026 | ₹14.19 |
| 10 Mar 2026 | ₹14.40 |
| 25 Mar 2026 | ₹14.23 |
| 13 Apr 2026 | ₹14.16 |
| 28 Apr 2026 | ₹14.71 |
| 14 May 2026 | ₹15.60 |
| 2 Jun 2026 | ₹15.46 |
| 17 Jun 2026 | ₹15.81 |
| 2 Jul 2026 | ₹16.74 |
| 17 Jul 2026 | ₹16.80 |
| 3 Aug 2026 | ₹17.30 |
| 18 Aug 2026 | ₹17.58 |
| 1 Sept 2026 | ₹17.67 |
| 17 Sept 2026 | ₹17.61 |
| 5 Oct 2026 | ₹17.07 |
| 21 Oct 2026 | ₹16.35 |
| 4 Nov 2026 | ₹17.71 |
| 20 Nov 2026 | ₹18.45 |
An open-ended sectoral fund from WhiteOak Capital Mutual Fund. Direct plan since February 2024. Figures for the Direct plan, Growth option.
- Fund size
- ₹964 Cr
- Category median ₹569 Cr
- Expense ratio
- 1.07%
- Category 1.01%
- 1Y return
- 26.8%
- Category 4.9%
- Deepest fall, whole history
- −15.4%
- Now −0.0%
- Top 10 holdings
- 46.9%
- 65 holdings
Returns against the category
| Period | This fundFund | Category medianCategory |
|---|---|---|
| 1 month1M | 12.0% | 10.0% |
| 3 months3M | 5.3% | 2.3% |
| 6 months6M | 17.1% | 10.3% |
| 1 year1Y | 26.8% | 4.9% |
| 3 years (a year)3Y | – | 14.6% |
| 5 years (a year)5Y | – | 14.3% |
| 10 years (a year)10Y | – | 16.5% |
| Since February 2024 (a year)Launch | 24.6% | 12.7% |
Ups and downs
Now · deepest ever −15.4% · chart from February 2024
| Date | Below peak |
|---|---|
| 6 Feb 2024 | 0.0% |
| 20 Mar 2024 | −6.0% |
| 7 May 2024 | −2.2% |
| 20 Jun 2024 | −0.7% |
| 1 Aug 2024 | 0.0% |
| 13 Sept 2024 | 0.0% |
| 28 Oct 2024 | −3.5% |
| 12 Dec 2024 | −0.6% |
| 24 Jan 2025 | −6.8% |
| 10 Mar 2025 | −12.9% |
| 25 Apr 2025 | −7.4% |
| 9 Jun 2025 | −4.2% |
| 18 Jul 2025 | −0.5% |
| 2 Sept 2025 | −3.3% |
| 15 Oct 2025 | −1.8% |
| 1 Dec 2025 | −1.0% |
| 13 Jan 2026 | −3.7% |
| 26 Feb 2026 | −0.8% |
| 15 Apr 2026 | −2.5% |
| 1 Jun 2026 | −2.0% |
| 13 Jul 2026 | −0.2% |
| 24 Aug 2026 | −1.4% |
| 7 Oct 2026 | −4.1% |
| 20 Nov 2026 | 0.0% |
- Volatility (3Y)
- –standard deviation, a year
- Deepest fall
- −15.4%from a peak, whole history
What it holds
Portfolio as disclosed for October 2026: 65 holdings, the ten largest 46.9% of the fund.
- Equity90.7%
- Debt4.1%
- Cash and equivalents5.3%
- Large cap27.3%
- Mid cap24.4%
- Small cap35.3%
- Health Care84.7%
- Others9.4%
- Materials4.6%
- Industrials1.4%
Largest holdings
- Divi's Laboratories LimitedPharmaceuticals & Biotechnology8.87%
- Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology6.68%
- Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology5.87%
- Laurus Labs LimitedPharmaceuticals & Biotechnology5.59%
- Clearing Corporation of India Ltd4.62%
- Apollo Hospitals Enterprise LimitedHealthcare Services3.73%
- Zydus Lifesciences LimitedPharmaceuticals & Biotechnology3.10%
- Sai Life Sciences LimitedPharmaceuticals & Biotechnology3.02%
- IPCA Laboratories LimitedPharmaceuticals & Biotechnology2.91%
- Mankind Pharma LimitedPharmaceuticals & Biotechnology2.50%
Fund size over time
From ₹443 Cr in September 2025; all plans together
| Month end | Fund size |
|---|---|
| 30 Sept 2025 | ₹443 Cr |
| 31 Oct 2025 | ₹480 Cr |
| 30 Nov 2025 | ₹502 Cr |
| 31 Dec 2025 | ₹509 Cr |
| 31 Jan 2026 | ₹492 Cr |
| 28 Feb 2026 | ₹533 Cr |
| 31 Mar 2026 | ₹556 Cr |
| 30 Apr 2026 | ₹603 Cr |
| 31 May 2026 | ₹664 Cr |
| 30 Jun 2026 | ₹741 Cr |
| 31 Jul 2026 | ₹825 Cr |
| 31 Aug 2026 | ₹902 Cr |
| 30 Sept 2026 | ₹927 Cr |
| 31 Oct 2026 | ₹964 Cr |
Key facts
- Plan and option
- Direct plan, Growth option
- Launched
- 6 Feb 2024
- Benchmark
- BSE Health Care - TRI
- Fund managers
- Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal
- Exit load
- Nil
- Minimum investment
- SIP ₹100 a month · one-time ₹500
- ISIN
- INF03VN01886
Other Sectoral funds
- ICICI Prudential Technology Fund6.3% 3Y a year₹13,154 Cr
- ICICI Prudential Banking and Financial Services Fund13.3% 3Y a year₹10,709 Cr
- SBI BANKING & FINANCIAL SERVICES FUND18.8% 3Y a year₹10,505 Cr
- Tata Digital India Fund4.4% 3Y a year₹9,985 Cr
- Nippon India Pharma Fund18.0% 3Y a year₹9,087 Cr
- ICICI Prudential Infrastructure Fund15.4% 3Y a year₹7,750 Cr
The largest other funds in the category by fund size, not a ranking. All Sectoral funds · Compare side by side
Questions about WhiteOak Capital Pharma and Heathcare Fund
What is the expense ratio of WhiteOak Capital Pharma and Heathcare Fund?
The Direct plan's expense ratio is 1.07% a year as of 31 Oct 2026. It is taken out of the fund's assets every day, so the NAV and the returns shown are already after it.
How large is WhiteOak Capital Pharma and Heathcare Fund?
WhiteOak Capital Pharma and Heathcare Fund manages ₹964 Cr as of 31 Oct 2026.
What returns has WhiteOak Capital Pharma and Heathcare Fund given?
1 year: 26.8% (category median 4.9%). Figures are for the Direct plan, Growth option, up to 20 Nov 2026. Past returns do not guarantee future returns.
How much does WhiteOak Capital Pharma and Heathcare Fund go up and down?
Its largest fall from a peak over its whole history was 15.4%.
What is the benchmark of WhiteOak Capital Pharma and Heathcare Fund?
The fund measures itself against the BSE Health Care - TRI.
Who manages WhiteOak Capital Pharma and Heathcare Fund?
Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak and Ashish Agrawal manage the fund.
Is there an exit load on WhiteOak Capital Pharma and Heathcare Fund?
Exit load: Nil.
What is the minimum investment in WhiteOak Capital Pharma and Heathcare Fund?
A SIP can start from ₹100 a month. A one-time investment can start from ₹500.
About the fund house, WhiteOak Capital Mutual Fund
WhiteOak Capital Mutual Fund runs 23 funds on this site, managing ₹48,232 Cr together.
